(THP = tetrahydro‐2H‐pyran‐2‐yl; n = 3, 4, 6, 8, 11; X = Cl, Br) afforded organotin(IV) compounds with the general formula Ph3Sn(CH2)nO–THP (1–5). The tetraorganotin(IV) compounds were characterized using multinuclear NMR and infrared spectroscopies and high‐resolution mass spectrometry. Anticancer activity of the synthesized compounds was tested in vitro against the A2780 (ovarian), A549 (lung), HeLa (adenocarcinoma)
SnPh 3 Li与X(CH 2)n O-THP(THP =四氢-2 H-
吡喃-2-基;n = 3、4、6、8、11 ; X = Cl,Br)的反应得到
有机锡(IV)与通式化合物博士3 SN(CH 2)ñ -O-THP(1 - 5)。使用多核NMR和红外光谱以及高分辨率质谱对四
有机锡(IV)化合物进行了表征。用SRB测定法在体外测试了合成化合物对A2780(卵巢),A549(肺),HeLa(腺癌)和SW480(结肠)肿瘤
细胞系的抗癌活性。在体外调查显示,当存在较短的链时,可获得较高的活性。然而化合物1 - 5被发现是比
顺铂活性较低。此外,活性最高的化合物1进入A2780细胞并通过触发内在和外在的半胱天冬酶途径引起凋亡。